GlassScriptPhysician profile
Edouard J Servy
NPI 1043208226
$809.55
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $225 · 2021: $309 · 2022: $30.31.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $202.54 | 2019-2021 | |
| Abbvie INC. | $161.24 | 2019-2022 | |
| Emd Serono, INC. | $155.11 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $46.38 | 2019 | |
| Ascend Therapeutics US, LLC | $39.85 | 2021 | |
| Vistapharm, INC. | $39.63 | 2021 | |
| Endo Pharmaceuticals INC. | $33.64 | 2020 | |
| Myovant Sciences INC. | $28.32 | 2021 | |
| Exeltis, USA INC. | $21.53 | 2021 | |
| Therapeuticsmd, INC. | $19.14 | 2019 | |
| Millicent US INC | $17.13 | 2019 | |
| Avion Pharmaceuticals | $15.98 | 2022 | |
| Amneal Pharmaceuticals LLC | $14.76 | 2019 | |
| Coloplast Corp | $14.30 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edouard Servy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.